Evidence map›Paper›PMID 28830384›Full record

ArticleBMC infectious diseases2017

Emergence and clonal transmission of multi-drug-resistant tuberculosis among patients in Chad.

Awa Ba Diallo, Gedeon W Ossoga, Geraldine Daneau, Seynabou Lo, Richard Ngandolo, Colette Diguimbaye Djaibé, Barou Djouater, Souleymane Mboup, Bouke C de Jong, Aissatou G Diallo and 1 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia.Journal of clinical tuberculosis and other mycobacterial diseases · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Multi-drug resistantAfrican journal of laboratory medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Awa Ba DialloMycobacteria Unit, Bacteriology- Virology Laboratory, CHU Aristide Le Dantec, 30 Avenue Pasteur, BP 7325, Dakar, Senegal. awa1.diallo@ucad.edu.sn.ORCID 0000-0003-3485-9828
Gedeon W OssogaInstitut de Recherche en Elevage pour le Developpement, N'Djamena, Chad.
Geraldine DaneauMycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Seynabou LoFaculty of Health Sciences, Gaston Berger University, Saint Louis, Senegal.
Richard NgandoloInstitut de Recherche en Elevage pour le Developpement, N'Djamena, Chad.
Colette Diguimbaye DjaibéClinique Médico-Chirurgicale PROVIDENCE, N'Djamena, Chad.
Barou DjouaterInstitut de Recherche en Elevage pour le Developpement, N'Djamena, Chad.
Souleymane MboupInstitut de Recherche en Santé, de Surveillance Epidemiologique et de Formation, Diamniadio, Senegal.
Bouke C de JongMycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Aissatou G DialloMycobacteria Unit, Bacteriology- Virology Laboratory, CHU Aristide Le Dantec, 30 Avenue Pasteur, BP 7325, Dakar, Senegal.
Florian GehreMycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmergence of Multidrug-resistant (MDR) strains constitutes a significant public health problem worldwide. Prevalence of MDR tuberculosis from Chad is unavailable to date.

methodsWe collected samples from consecutive TB patients nationwide in the seven major cities of Chad between 2007 and 2012 to characterize drug resistance and the population structure of circulating Mycobacterium tuberculosis complex (MTBC) strains. We tested drug sensitivity using Line Probe Assays and phenotypic drug susceptibility testing (DST) were used for second line drugs. We genotyped the isolates using spoligotype analysis and MIRU-VNTR.

resultsA total of 311 cultures were isolated from 593 patients. The MDR prevalence was 0.9% among new patients and 3.5% among retreatment patients, and no second line drug resistance was identified. The distribution of genotypes suggests a dissemination of MDR strains in the Southern city of Moundou, bordering Cameroon and Central African Republic.

conclusionEmerging MDR isolates pose a public health threat to Southern Chad, with risk to neighboring countries. This study informs public health practitioners, justifying the implementation of continuous surveillance with DST for all retreatment cases as well as contacts of MDR patients, in parallel with provision of adequate 2nd line regimens in the region.

Indexed as

Drug Resistance, Multiple, BacterialGenetic VariationAntitubercular AgentsChadClone CellsCommunicable Diseases, EmergingFemaleGenotypeHumansMaleMiddle AgedMycobacterium tuberculosisPrevalenceTuberculosis, Multidrug-ResistantAntitubercular AgentsChadMDRMolecular characterizationMycobacterium tuberculosis

Identifiers

PMID28830384
PMCPMC5567628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.